2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
RCOG World Congress 2025
June 23 - 25, 2025 | ExCeL London, UK
EP.0952
DELTA NEUTROPHIL INDEX AND SERUM CALPROTECTIN LEVELS IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
Poster Presenter
Part of Topic
High risk pregnancy
Video
DELTA NEUTROPHIL INDEX AND SERUM CALPROTECTIN LEVELS IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
Intrahepatic Cholestasis of Pregnancy is a condition characterized by pruritus without any associated skin rash along with elevation in the serum bile acid levels ,typically in the late trimesters which resolves after delivery
Adverse Outcomes
Currently, Serum Bile acid is the standard diagnostic marker for IHCP
Serum delta neutrophil index (DNI), a new inflammatory marker, reflects the ratio of circulating immature granulocytes related to infection and inflammation to the total number of neutrophils.
DNI % = (Neutrophil% + Eosinophil% ) – Poly Morpho Nuclear Leucocyte %
Calprotectin (S100 A8 /A9), a Ca++ Binding protein belonging to the S100 family is also known as the 27E10 antigen, is a protein that is expressed on immunocytes & stimulates the production of cytokines & leucocyte production
The Serum Calprotectin were calculated using the Human Calprotectin ELISA© Cat.no E4010Hu , which was a sandwich ELISA kit for the accurate quantitative detection of human Calprotectin (also known as CAL) in serum, plasma, cell culture supernates, cell lysates, tissue homogenates. The kit’s Standard Curve Range was between 2ng/ml - 600ng/ml with a sensitivity of 1.67ng/ml.
To find the association of maternal Delta Neutrophil Index & serum Calprotectin levels with Intrahepatic Cholestasis of Pregnancy.
To find the co-relation between both DNI & Serum Calprotectin levels with bile acids in antenatal women with Intrahepatic Cholestasis of Pregnancy
STUDY DESIGN: Prospective observational study
STUDY DURATION: 18 months
INCLUSION CRITERIA :
Women with singleton pregnancy > 28 weeks of gestation with complaint of itching and elevated Serum liver Transaminases ALT and AST >40 IU/ml.
EXCLUSION CRITERIA :
Patients on prior medication (ursodeoxycholic acid)
